CHILDREN'S TYLENOL PLUS COUGH & RUNNY NOSE OTC
Generic Name and Formulations:
Acetaminophen 160mg, chlorpheniramine maleate 1mg, dextromethorphan HBr 5mg; per 5mL; liq; cherry flavor.
McNeil Consumer Healthcare
Indications for CHILDREN'S TYLENOL PLUS COUGH & RUNNY NOSE:
Rhinorrhea, cough, sore throat, fever, headache, minor aches and pains.
<4yrs (<36lbs): do not use. 4–5yrs (36–47lbs): not recommended. 6–11yrs (48–95lbs): 10mL every 4 hours as needed; max 5 doses/24 hours.
Children <4yrs old (<36lbs). During or within 14 days of MAOIs. Concomitant other acetaminophen products. For use as a sedative hypnotic.
Hepatic dysfunction. Glaucoma. GI or GU obstruction. Asthma. Lower respiratory disorders.
See Contraindications. Hypertensive crisis with MAOIs. Increased CNS effects with other CNS depressants.
Analgesic + antihistamine + antitussive.
Drowsiness, anticholinergic effects, excitability, hepatotoxicity (overdosage).
Endocrinology Advisor Articles
- Imaging Studies in Hypothyroidism Evaluation Linked to Unnecessary Risks
- Transoral Endoscopic Thyroidectomy Vestibular Approach: Safety and Outcomes
- Once-Weekly Omarigliptin Improves Glycemic Control in Type 2 Diabetes
- Insulin Glargine Associated With Breast Cancer Risk in T2D
- High Grip Strength Associated With Lower Risk for Diabetes-Related AEs
- Update on Vitamin D and Calcium Supplements for Reducing Fracture Risk
- Lower Risk for SGLT2i-Associated Genitourinary Infection With DPP-4i
- Bariatric Surgery: An Effective Treatment for Type 2 Diabetes
- Severe Hypoglycemia Associated With Increased Mortality Risk in T2D
- Efficacy of CGM in Preterm Infants of Mothers With Diabetes
- Increased Risk of Diabetes, Post-Diabetes Pneumonia for Patients With COPD
- Pancreatic Exocrine Dysfunction Occurs After Islet Autoimmunity in T1D
- T2D in African American Women Ups ER-negative Breast Cancer Risk
- High-Sensitivity CRP and LDL-C Predictive of Subsequent MACE in T2D
- Risks Associated With Denosumab Discontinuation